主要股东
注:以下部分股东代表特定权益共同体,直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | 领航集团有限公司 | 是 | 22937.26万 | 9.52% | 不变 | 不变 | -- |
| 2 | 贝莱德集团公司 | 是 | 18630.83万 | 7.70% | 不变 | 不变 | -- |
| 3 | 美国道富集团 | 是 | 13299.63万 | 5.50% | 不变 | 不变 | -- |
| 4 | Joaquin Duato | 否 | 40.78万 | 0.02% |
|
|
0.0169% |
| 5 | Jennifer L. Taubert | 否 | 17.80万 | 0.0074% |
|
|
0.0074% |
| 6 | Joseph J. Wolk | 否 | 8.49万 | 0.0035% |
|
|
0.0035% |
| 7 | Tim Schmid | 否 | 1.77万 | 0.0007% | 新增 | 新增 | 0.0007% |
| 8 | John C. Reed | 否 | 1.55万 | 0.0006% |
|
|
0.0006% |
| 9 | Anne M. Mulcahy | 否 | 0.84万 | 0.0003% |
|
|
0.0003% |
| 10 | H. Joly | 否 | 0.50万 | 0.0002% | 不变 | 不变 | 0.0002% |
| 11 | Marillyn A. Hewson | 否 | 0.30万 | 0.0001% | 新增 | 新增 | 0.0001% |
| 12 | Darius Adamczyk | 否 | 0.11万 | 0.00% | 不变 | 不变 | 0.0000% |
| 13 | M. A. Weinberger | 否 | 0.10万 | 0.00% | 新增 | 新增 | 0.0000% |
| 14 | Eugene A. Woods | 否 | 0.03万 | 0.00% | 新增 | 新增 | 0.0000% |
| 15 | Paula A. Johnson | 否 | 0.02万 | 0.00% | 不变 | 不变 | 0.0000% |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2025-11-26 | MORIKIS JOHN G |
|
0.18 | 206.15 | 是 | -- |
| 2025-10-17 | REED JOHN C |
|
3.24 | 157.92 | 是 | EVP, Innovative Medicine, R&D |
| 2025-10-17 | REED JOHN C |
|
1.07 | 192.71 | 是 | EVP, Innovative Medicine, R&D |
| 2025-09-04 | Taubert Jennifer L |
|
17.80 | 177.81 | 是 | EVP, WWC. Innovative Medicine |
| 2025-09-04 | Taubert Jennifer L |
|
23.45 | 101.87 | 是 | EVP, WWC. Innovative Medicine |
| 2025-08-29 | Forminard Elizabeth |
|
2.24 | 115.67 | 是 | Executive VP, General Counsel |
| 2025-08-29 | Forminard Elizabeth |
|
1.29 | 177.20 | 是 | Executive VP, General Counsel |
| 2025-08-22 | Duato Joaquin |
|
40.18 | 101.87 | 是 | CEO and Chairman of the Board |
| 2025-08-22 | Duato Joaquin |
|
27.60 | 179.21 | 是 | CEO and Chairman of the Board |
| 2025-08-15 | Wolk Joseph J |
|
3.08 | 101.87 | 是 | Exec VP, CFO |
| 2025-08-15 | Wolk Joseph J |
|
1.40 | 176.91 | 是 | Exec VP, CFO |
| 2025-07-17 | REED JOHN C |
|
1.07 | 163.55 | 是 | EVP, Innovative Medicine, R&D |
| 2025-05-01 | REED JOHN C |
|
4.08 | 0.00 | 是 | EVP, Innovative Medicine, R&D |
| 2025-05-01 | REED JOHN C |
|
2.98 | 156.31 | 是 | EVP, Innovative Medicine, R&D |
| 2025-03-18 | Duato Joaquin |
|
27.60 | 0.00 | 是 | CEO and Chairman of the Board |
| 2025-02-25 | Decker Robert J |
|
2.80 | 101.87 | 是 | VP Corporate Controller |
| 2025-02-25 | Decker Robert J |
|
2.10 | 165.88 | 是 | VP Corporate Controller |
| 2025-02-15 | REED JOHN C |
|
1.59 | 0.00 | 是 | EVP, Innovative Medicine, R&D |
| 2025-02-15 | REED JOHN C |
|
1.55 | 156.15 | 是 | EVP, Innovative Medicine, R&D |
| 2025-02-14 | Schmid Timothy |
|
1.79 | 0.00 | 是 | EVP, WW Chair, MedTech |
| 2025-02-14 | Schmid Timothy |
|
1.69 | 156.71 | 是 | EVP, WW Chair, MedTech |
| 2025-02-13 | Broadhurst Vanessa |
|
2.02 | 0.00 | 是 | EVP, Global Corp Affairs |
| 2025-02-13 | Broadhurst Vanessa |
|
2.01 | 155.26 | 是 | EVP, Global Corp Affairs |
| 2025-02-13 | Broadhurst Vanessa |
|
2.19 | 0.00 | 是 | EVP, Global Corp Affairs |
| 2025-02-13 | Broadhurst Vanessa |
|
2.13 | 156.71 | 是 | EVP, Global Corp Affairs |
| 2025-02-13 | Broadhurst Vanessa |
|
2.18 | 0.00 | 是 | EVP, Global Corp Affairs |
| 2025-02-13 | Broadhurst Vanessa |
|
2.17 | 156.15 | 是 | EVP, Global Corp Affairs |
| 2025-02-13 | Broadhurst Vanessa |
|
2.46 | 0.00 | 是 | EVP, Global Corp Affairs |
| 2025-02-13 | Broadhurst Vanessa |
|
2.36 | 156.71 | 是 | EVP, Global Corp Affairs |
| 2025-02-13 | Duato Joaquin |
|
39.25 | 0.00 | 是 | CEO and Chairman of the Board |
| 2025-02-13 | Duato Joaquin |
|
39.10 | 155.26 | 是 | CEO and Chairman of the Board |
| 2025-02-13 | Duato Joaquin |
|
39.60 | 0.00 | 是 | CEO and Chairman of the Board |
| 2025-02-13 | Duato Joaquin |
|
39.38 | 156.71 | 是 | CEO and Chairman of the Board |
| 2025-02-13 | Duato Joaquin |
|
39.75 | 0.00 | 是 | CEO and Chairman of the Board |
| 2025-02-13 | Duato Joaquin |
|
39.59 | 156.15 | 是 | CEO and Chairman of the Board |
| 2025-02-13 | Duato Joaquin |
|
41.52 | 0.00 | 是 | CEO and Chairman of the Board |
| 2025-02-13 | Duato Joaquin |
|
40.68 | 156.71 | 是 | CEO and Chairman of the Board |
| 2025-02-13 | Decker Robert J |
|
1.93 | 0.00 | 是 | VP Corporate Controller |
| 2025-02-13 | Decker Robert J |
|
1.92 | 155.26 | 是 | VP Corporate Controller |
| 2025-02-13 | Decker Robert J |
|
2.00 | 0.00 | 是 | VP Corporate Controller |
| 2025-02-13 | Decker Robert J |
|
1.98 | 156.71 | 是 | VP Corporate Controller |
| 2025-02-13 | Decker Robert J |
|
2.01 | 0.00 | 是 | VP Corporate Controller |
| 2025-02-13 | Forminard Elizabeth |
|
0.90 | 0.00 | 是 | Executive VP, General Counsel |
| 2025-02-13 | Forminard Elizabeth |
|
0.88 | 155.26 | 是 | Executive VP, General Counsel |
| 2025-02-13 | Forminard Elizabeth |
|
1.00 | 156.15 | 是 | Executive VP, General Counsel |
| 2025-02-13 | Forminard Elizabeth |
|
1.14 | 0.00 | 是 | Executive VP, General Counsel |
| 2025-02-13 | Forminard Elizabeth |
|
1.09 | 156.71 | 是 | Executive VP, General Counsel |
| 2025-02-13 | Forminard Elizabeth |
|
0.96 | 0.00 | 是 | Executive VP, General Counsel |
| 2025-02-13 | Forminard Elizabeth |
|
0.94 | 156.71 | 是 | Executive VP, General Counsel |
| 2025-02-13 | Forminard Elizabeth |
|
1.03 | 0.00 | 是 | Executive VP, General Counsel |
| 2025-02-13 | Decker Robert J |
|
2.14 | 0.00 | 是 | VP Corporate Controller |
| 2025-02-13 | Decker Robert J |
|
2.10 | 156.71 | 是 | VP Corporate Controller |
| 2025-02-13 | Mulholland Kristen |
|
1.21 | 0.00 | 是 | EVP, Chief HR Officer |
| 2025-02-13 | Mulholland Kristen |
|
1.20 | 155.26 | 是 | EVP, Chief HR Officer |
| 2025-02-13 | Mulholland Kristen |
|
1.30 | 0.00 | 是 | EVP, Chief HR Officer |
| 2025-02-13 | Mulholland Kristen |
|
1.27 | 156.71 | 是 | EVP, Chief HR Officer |
| 2025-02-13 | Mulholland Kristen |
|
1.31 | 0.00 | 是 | EVP, Chief HR Officer |
| 2025-02-13 | Mulholland Kristen |
|
1.30 | 156.15 | 是 | EVP, Chief HR Officer |
| 2025-02-13 | Mulholland Kristen |
|
1.46 | 0.00 | 是 | EVP, Chief HR Officer |
| 2025-02-13 | Mulholland Kristen |
|
1.41 | 156.71 | 是 | EVP, Chief HR Officer |
| 2025-02-13 | Taubert Jennifer L |
|
16.72 | 0.00 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-13 | Taubert Jennifer L |
|
16.68 | 155.26 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-13 | Taubert Jennifer L |
|
17.09 | 0.00 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-13 | Taubert Jennifer L |
|
16.95 | 156.71 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-13 | Taubert Jennifer L |
|
17.11 | 0.00 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-13 | Taubert Jennifer L |
|
17.05 | 156.15 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-13 | Taubert Jennifer L |
|
18.59 | 0.00 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-13 | Taubert Jennifer L |
|
17.80 | 156.71 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-13 | Swanson James D. |
|
1.50 | 0.00 | 是 | EVP, CIO |
| 2025-02-13 | Swanson James D. |
|
1.49 | 155.26 | 是 | EVP, CIO |
| 2025-02-13 | Swanson James D. |
|
1.68 | 0.00 | 是 | EVP, CIO |
| 2025-02-13 | Swanson James D. |
|
1.63 | 156.71 | 是 | EVP, CIO |
| 2025-02-13 | Swanson James D. |
|
1.68 | 0.00 | 是 | EVP, CIO |
| 2025-02-13 | Swanson James D. |
|
1.66 | 156.15 | 是 | EVP, CIO |
| 2025-02-13 | Swanson James D. |
|
1.97 | 0.00 | 是 | EVP, CIO |
| 2025-02-13 | Swanson James D. |
|
1.88 | 156.71 | 是 | EVP, CIO |
| 2025-02-13 | Wolk Joseph J |
|
0.18 | 0.00 | 是 | Exec VP, CFO |
| 2025-02-13 | Wolk Joseph J |
|
0.13 | 155.26 | 是 | Exec VP, CFO |
| 2025-02-13 | Wolk Joseph J |
|
0.53 | 0.00 | 是 | Exec VP, CFO |
| 2025-02-13 | Wolk Joseph J |
|
0.41 | 156.71 | 是 | Exec VP, CFO |
| 2025-02-13 | Wolk Joseph J |
|
0.61 | 0.00 | 是 | Exec VP, CFO |
| 2025-02-13 | Wolk Joseph J |
|
0.53 | 156.15 | 是 | Exec VP, CFO |
| 2025-02-13 | Wolk Joseph J |
|
2.07 | 0.00 | 是 | Exec VP, CFO |
| 2025-02-13 | Wolk Joseph J |
|
1.40 | 156.71 | 是 | Exec VP, CFO |
| 2025-02-13 | Wengel Kathryn E |
|
8.96 | 0.00 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-13 | Wengel Kathryn E |
|
8.94 | 155.26 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-13 | Wengel Kathryn E |
|
9.09 | 0.00 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-13 | Wengel Kathryn E |
|
9.04 | 156.71 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-13 | Wengel Kathryn E |
|
9.10 | 0.00 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-13 | Wengel Kathryn E |
|
9.08 | 156.15 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-13 | Wengel Kathryn E |
|
9.67 | 0.00 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-13 | Wengel Kathryn E |
|
9.43 | 156.71 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-13 | Schmid Timothy |
|
1.35 | 0.00 | 是 | EVP, WW Chair, MedTech |
| 2025-02-13 | Schmid Timothy |
|
1.33 | 155.26 | 是 | EVP, WW Chair, MedTech |
| 2025-02-13 | Schmid Timothy |
|
1.51 | 0.00 | 是 | EVP, WW Chair, MedTech |
| 2025-02-13 | Schmid Timothy |
|
1.45 | 156.71 | 是 | EVP, WW Chair, MedTech |
| 2025-02-13 | Schmid Timothy |
|
1.55 | 0.00 | 是 | EVP, WW Chair, MedTech |
| 2025-02-13 | Schmid Timothy |
|
1.51 | 156.15 | 是 | EVP, WW Chair, MedTech |
| 2025-02-07 | Taubert Jennifer L |
|
21.34 | 100.06 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-07 | Taubert Jennifer L |
|
16.59 | 153.12 | 是 | EVP, WWC. Innovative Medicine |
| 2025-02-07 | Wengel Kathryn E |
|
11.50 | 100.06 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-07 | Wengel Kathryn E |
|
8.90 | 153.12 | 是 | EVP, Chief TO and Risk Officer |
| 2025-02-07 | Duato Joaquin |
|
48.97 | 100.06 | 是 | CEO and Chairman of the Board |
| 2025-02-07 | Duato Joaquin |
|
38.90 | 153.12 | 是 | CEO and Chairman of the Board |
| 2024-12-12 | WEINBERGER MARK A |
|
0.10 | 147.22 | 是 | -- |
| 2024-08-30 | Decker Robert J |
|
2.46 | 100.06 | 是 | VP Corporate Controller |
| 2024-08-30 | Decker Robert J |
|
1.90 | 165.06 | 是 | VP Corporate Controller |
| 2024-07-08 | Broadhurst Vanessa |
|
2.49 | 0.00 | 是 | EVP, Global Corp Affairs |
| 2024-07-08 | Broadhurst Vanessa |
|
1.98 | 147.16 | 是 | EVP, Global Corp Affairs |
| 2024-05-22 | Wolk Joseph J |
|
-- | 0.00 | 是 | Exec VP, CFO |
| 2024-05-01 | REED JOHN C |
|
2.26 | 0.00 | 是 | EVP, Innovative Medicine, R&D |
| 2024-05-01 | REED JOHN C |
|
1.46 | 144.59 | 是 | EVP, Innovative Medicine, R&D |
| 2024-03-13 | Broadhurst Vanessa |
|
1.50 | 162.16 | 是 | EVP, Global Corp Affairs |
| 2024-02-13 | Fasolo Peter |
|
11.26 | 0.00 | 是 | Exec VP, Chief HR Officer |
| 2024-02-13 | Fasolo Peter |
|
11.21 | 157.85 | 是 | Exec VP, Chief HR Officer |
| 2024-02-13 | Duato Joaquin |
|
36.48 | 0.00 | 是 | CEO and Chairman of the Board |
| 2024-02-13 | Duato Joaquin |
|
36.33 | 157.85 | 是 | CEO and Chairman of the Board |
| 2024-02-13 | Wengel Kathryn E |
|
8.26 | 0.00 | 是 | EVP, Chief TO and Risk Officer |
| 2024-02-13 | Wengel Kathryn E |
|
8.23 | 157.85 | 是 | EVP, Chief TO and Risk Officer |
| 2024-02-13 | Taubert Jennifer L |
|
15.49 | 157.85 | 是 | EVP, WWC. Innovative Medicine |
| 2024-02-13 | Wolk Joseph J |
|
6.97 | 0.00 | 是 | Exec VP, CFO |
| 2024-02-13 | Wolk Joseph J |
|
6.89 | 157.85 | 是 | Exec VP, CFO |
| 2024-02-13 | Taubert Jennifer L |
|
15.55 | 0.00 | 是 | EVP, WWC. Innovative Medicine |
| 2024-02-13 | Decker Robert J |
|
1.91 | 0.00 | 是 | VP Corporate Controller |
| 2024-02-13 | Swanson James D. |
|
1.46 | 157.85 | 是 | EVP, CIO |
| 2024-02-13 | Swanson James D. |
|
1.48 | 0.00 | 是 | EVP, CIO |
| 2024-02-13 | Broadhurst Vanessa |
|
2.41 | 0.00 | 是 | EVP, Global Corp Affairs |
| 2024-02-13 | Broadhurst Vanessa |
|
2.39 | 157.85 | 是 | EVP, Global Corp Affairs |
| 2024-02-13 | Hait William |
|
3.91 | 0.00 | 是 | -- |
| 2024-02-13 | Hait William |
|
3.86 | 157.85 | 是 | -- |
| 2024-02-13 | Forminard Elizabeth |
|
0.86 | 0.00 | 是 | Executive VP, General Counsel |
| 2024-02-13 | Forminard Elizabeth |
|
0.83 | 157.85 | 是 | Executive VP, General Counsel |
| 2024-02-13 | Schmid Timothy |
|
1.33 | 0.00 | 是 | EVP, WW Chair, MedTech |
| 2024-02-13 | Schmid Timothy |
|
1.30 | 157.85 | 是 | EVP, WW Chair, MedTech |
| 2024-02-12 | Broadhurst Vanessa |
|
2.51 | 0.00 | 是 | EVP, Global Corp Affairs |
| 2024-02-12 | Broadhurst Vanessa |
|
2.59 | 0.00 | 是 | EVP, Global Corp Affairs |
| 2024-02-12 | Broadhurst Vanessa |
|
2.37 | 157.40 | 是 | EVP, Global Corp Affairs |
| 2024-02-12 | Fasolo Peter |
|
11.65 | 0.00 | 是 | Exec VP, Chief HR Officer |
| 2024-02-12 | Fasolo Peter |
|
11.86 | 0.00 | 是 | Exec VP, Chief HR Officer |
| 2024-02-12 | Fasolo Peter |
|
11.16 | 157.40 | 是 | Exec VP, Chief HR Officer |
| 2024-02-12 | Taubert Jennifer L |
|
15.42 | 157.40 | 是 | EVP, WWC. Innovative Medicine |
| 2024-02-12 | Duato Joaquin |
|
37.20 | 0.00 | 是 | CEO and Chairman of the Board |
| 2024-02-12 | Duato Joaquin |
|
37.72 | 0.00 | 是 | CEO and Chairman of the Board |
| 2024-02-12 | Duato Joaquin |
|
36.13 | 157.40 | 是 | CEO and Chairman of the Board |
| 2024-02-12 | Wolk Joseph J |
|
7.50 | 0.00 | 是 | Exec VP, CFO |
| 2024-02-12 | Wolk Joseph J |
|
7.87 | 0.00 | 是 | Exec VP, CFO |
| 2024-02-12 | Wolk Joseph J |
|
6.79 | 157.40 | 是 | Exec VP, CFO |
| 2024-02-12 | Taubert Jennifer L |
|
16.38 | 0.00 | 是 | EVP, WWC. Innovative Medicine |
| 2024-02-12 | Taubert Jennifer L |
|
16.76 | 0.00 | 是 | EVP, WWC. Innovative Medicine |
| 2024-02-12 | Hait William |
|
3.82 | 157.40 | 是 | -- |
| 2024-02-12 | Forminard Elizabeth |
|
0.85 | 0.00 | 是 | Executive VP, General Counsel |
| 2024-02-12 | Decker Robert J |
|
1.90 | 0.00 | 是 | VP Corporate Controller |
| 2024-02-12 | Forminard Elizabeth |
|
0.90 | 0.00 | 是 | Executive VP, General Counsel |
| 2024-02-12 | Forminard Elizabeth |
|
0.79 | 157.40 | 是 | Executive VP, General Counsel |
| 2024-02-12 | Decker Robert J |
|
1.93 | 0.00 | 是 | VP Corporate Controller |
| 2024-02-12 | Decker Robert J |
|
1.87 | 157.40 | 是 | VP Corporate Controller |
| 2024-02-12 | Swanson James D. |
|
1.52 | 0.00 | 是 | EVP, CIO |
| 2024-02-12 | Swanson James D. |
|
1.60 | 0.00 | 是 | EVP, CIO |
| 2024-02-12 | Swanson James D. |
|
1.43 | 157.40 | 是 | EVP, CIO |
| 2024-02-12 | Hait William |
|
4.10 | 0.00 | 是 | -- |
| 2024-02-12 | Hait William |
|
4.23 | 0.00 | 是 | -- |
| 2024-02-12 | Schmid Timothy |
|
1.49 | 0.00 | 是 | EVP, WW Chair, MedTech |
| 2024-02-12 | Schmid Timothy |
|
1.57 | 0.00 | 是 | EVP, WW Chair, MedTech |
| 2024-02-12 | Schmid Timothy |
|
1.28 | 157.40 | 是 | EVP, WW Chair, MedTech |
| 2024-02-12 | Wengel Kathryn E |
|
8.70 | 0.00 | 是 | EVP, Chief TO and Risk Officer |
| 2024-02-12 | Wengel Kathryn E |
|
8.90 | 0.00 | 是 | EVP, Chief TO and Risk Officer |
| 2024-02-12 | Wengel Kathryn E |
|
8.19 | 157.40 | 是 | EVP, Chief TO and Risk Officer |
| 2024-02-09 | Duato Joaquin |
|
43.93 | 90.44 | 是 | CEO and Chairman of the Board |
| 2024-02-09 | Duato Joaquin |
|
34.06 | 156.76 | 是 | CEO and Chairman of the Board |
| 2024-02-09 | Wengel Kathryn E |
|
10.25 | 90.44 | 是 | EVP, Chief TO and Risk Officer |
| 2024-02-09 | Wengel Kathryn E |
|
7.52 | 156.76 | 是 | EVP, Chief TO and Risk Officer |
| 2024-02-08 | Duato Joaquin |
|
31.06 | 0.00 | 是 | CEO and Chairman of the Board |
| 2024-02-08 | Duato Joaquin |
|
30.83 | 156.33 | 是 | CEO and Chairman of the Board |
| 2024-02-08 | Wolk Joseph J |
|
5.39 | 0.00 | 是 | Exec VP, CFO |
| 2024-02-08 | Wolk Joseph J |
|
5.29 | 156.33 | 是 | Exec VP, CFO |
| 2024-02-08 | Taubert Jennifer L |
|
14.33 | 0.00 | 是 | EVP, WW Chair, Pharmaceuticals |
| 2024-02-08 | Taubert Jennifer L |
|
14.14 | 156.33 | 是 | EVP, WW Chair, Pharmaceuticals |
| 2024-02-08 | Taubert Jennifer L |
|
20.08 | 90.44 | 是 | EVP, WW Chair, Pharmaceuticals |
| 2024-02-08 | Taubert Jennifer L |
|
14.14 | 156.27 | 是 | EVP, WW Chair, Pharmaceuticals |
| 2024-02-08 | Wengel Kathryn E |
|
6.79 | 0.00 | 是 | EVP, Chief TO and Risk Officer |
| 2024-02-08 | Wengel Kathryn E |
|
6.69 | 156.33 | 是 | EVP, Chief TO and Risk Officer |
| 2024-02-08 | Swanson James D. |
|
1.11 | 0.00 | 是 | -- |
| 2024-02-08 | Swanson James D. |
|
1.06 | 156.33 | 是 | -- |
| 2024-02-08 | Forminard Elizabeth |
|
0.65 | 0.00 | 是 | Executive VP, General Counsel |
| 2024-02-08 | Forminard Elizabeth |
|
0.61 | 156.33 | 是 | Executive VP, General Counsel |
| 2024-02-08 | Fasolo Peter |
|
10.37 | 156.33 | 是 | Exec VP, Chief HR Officer |
| 2024-02-08 | Fasolo Peter |
|
10.45 | 0.00 | 是 | Exec VP, Chief HR Officer |
| 2024-02-08 | Decker Robert J |
|
1.76 | 0.00 | 是 | VP Corporate Controller |
| 2024-02-08 | Decker Robert J |
|
1.74 | 156.33 | 是 | VP Corporate Controller |
| 2024-02-08 | Hait William |
|
3.45 | 0.00 | 是 | -- |
| 2024-02-08 | Hait William |
|
3.34 | 156.33 | 是 | -- |
| 2024-02-08 | Schmid Timothy |
|
1.09 | 0.00 | 是 | EVP, WW Chair, MedTech |
| 2024-02-08 | Schmid Timothy |
|
0.99 | 156.33 | 是 | EVP, WW Chair, MedTech |
| 2024-02-08 | Broadhurst Vanessa |
|
2.11 | 0.00 | 是 | EVP, Global Corp Affairs |
| 2024-02-08 | Broadhurst Vanessa |
|
2.04 | 156.33 | 是 | EVP, Global Corp Affairs |